Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuko Nishimura

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|August 11, 2005
Versatile diastereoselectivity in formal [3,3]-sigmatropic shifts of substituted 1-alkenyl-3-alkylidenecyclobutanols and their silyl ethersMichael E Jung, Nobuko Nishimura, Aaron R Novack
Molecular Pain|December 19, 2007
Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonistsLana Klionsky, Rami Tamir, Baoxi Gao, et al.
Journal of Medicinal Chemistry|February 15, 2012
Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonistsNuria A Tamayo, Yunxin Bo, Vijay Gore, et al.
Journal of Medicinal Chemistry|June 26, 2007
Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic propertiesHui-Ling Wang, Jodie Katon, Chenera Balan, et al.
Journal of Medicinal Chemistry|June 26, 2007
Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamidesMark H Norman, Jiawang Zhu, Christopher Fotsch, et al.
Bioorganic & Medicinal Chemistry|April 18, 2016
Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profilingLongbin Liu, Matthew R Lee, Joseph L Kim, et al.
Journal of Medicinal Chemistry|April 28, 2015
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational AnalysisNuria A Tamayo, Mark H Norman, Michael D Bartberger, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2012
Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffoldRyan P Wurz, Longbin Liu, Kevin Yang, et al.
Journal of Medicinal Chemistry|March 12, 2014
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 3. Structure-activity relationships within the aryl carbinol region of the N-arylsulfonamido-N'-arylpiperazine seriesNobuko Nishimura, Mark H Norman, Longbin Liu, et al.
Journal of Medicinal Chemistry|March 7, 2014
Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel B Horne, Nuria A Tamayo, Michael D Bartberger, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|August 11, 2005
Versatile diastereoselectivity in formal [3,3]-sigmatropic shifts of substituted 1-alkenyl-3-alkylidenecyclobutanols and their silyl ethersMichael E Jung, Nobuko Nishimura, Aaron R Novack
Molecular Pain|December 19, 2007
Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonistsLana Klionsky, Rami Tamir, Baoxi Gao, et al.
Journal of Medicinal Chemistry|February 15, 2012
Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonistsNuria A Tamayo, Yunxin Bo, Vijay Gore, et al.
Journal of Medicinal Chemistry|June 26, 2007
Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic propertiesHui-Ling Wang, Jodie Katon, Chenera Balan, et al.
Journal of Medicinal Chemistry|June 26, 2007
Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamidesMark H Norman, Jiawang Zhu, Christopher Fotsch, et al.
Bioorganic & Medicinal Chemistry|April 18, 2016
Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profilingLongbin Liu, Matthew R Lee, Joseph L Kim, et al.
Journal of Medicinal Chemistry|April 28, 2015
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational AnalysisNuria A Tamayo, Mark H Norman, Michael D Bartberger, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2012
Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffoldRyan P Wurz, Longbin Liu, Kevin Yang, et al.
Journal of Medicinal Chemistry|March 12, 2014
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 3. Structure-activity relationships within the aryl carbinol region of the N-arylsulfonamido-N'-arylpiperazine seriesNobuko Nishimura, Mark H Norman, Longbin Liu, et al.
Journal of Medicinal Chemistry|March 7, 2014
Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel B Horne, Nuria A Tamayo, Michael D Bartberger, et al.
Pageof 2